Fortress Biotech, Inc. total revenue, net income and dynamics of changes in US dollar today
Fortress Biotech, Inc. revenue for the past few reporting periods. The dynamics of Fortress Biotech, Inc. net income fell by -3 527 000 $ for the last reporting period. These are the main financial indicators of Fortress Biotech, Inc.. The financial graph of Fortress Biotech, Inc. displays the online status: net income, net revenue, total assets. The financial report schedule from 30/06/2017 to 31/03/2021 is available online. All information on Fortress Biotech, Inc. total revenue on this chart is created in the form of yellow bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
11 587 000 $
+78.89 % ↑
-8 822 000 $
-733.764 % ↓
31/12/2020
13 749 000 $
-
-5 295 000 $
-
30/09/2020
9 475 000 $
-85.124 % ↓
-15 547 000 $
-
30/06/2020
9 457 000 $
-85.185 % ↓
-13 314 000 $
-
31/03/2019
6 477 000 $
-
1 392 000 $
-
31/12/2018
0 $
-
0 $
-
30/09/2018
63 693 000 $
-
-16 638 000 $
-
30/06/2018
63 834 000 $
-
-21 611 000 $
-
31/03/2018
55 425 000 $
-
-21 018 000 $
-
31/12/2017
42 103 000 $
-
-10 413 000 $
-
30/09/2017
33 665 000 $
-
-27 116 000 $
-
30/06/2017
35 940 000 $
-
-17 365 000 $
-
Show:
to
Fortress Biotech, Inc. financial report charts
The latest dates of Fortress Biotech, Inc. financial statements available online: 30/06/2017, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest financial report of Fortress Biotech, Inc. is available online for such a date - 31/03/2021. Gross profit Fortress Biotech, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Fortress Biotech, Inc. is -12 475 000 $
Fortress Biotech, Inc. quarterly report dates
Cost of revenue Fortress Biotech, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Fortress Biotech, Inc. is 24 062 000 $ Total revenue Fortress Biotech, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Fortress Biotech, Inc. is 11 587 000 $ Operating income Fortress Biotech, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Fortress Biotech, Inc. is -30 017 000 $
Net income Fortress Biotech, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Fortress Biotech, Inc. is -8 822 000 $ Current assets Fortress Biotech, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Fortress Biotech, Inc. is 317 993 000 $ Total assets Fortress Biotech, Inc. refers to the total amount of assets owned by a person or entity. Total assets Fortress Biotech, Inc. is 391 043 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
-12 475 000 $
9 468 000 $
6 096 000 $
6 333 000 $
4 593 000 $
-
12 376 000 $
11 671 000 $
10 392 000 $
40 297 000 $
33 160 000 $
35 062 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
24 062 000 $
4 281 000 $
3 379 000 $
3 124 000 $
1 884 000 $
-
51 317 000 $
52 163 000 $
45 033 000 $
1 806 000 $
505 000 $
878 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
11 587 000 $
13 749 000 $
9 475 000 $
9 457 000 $
6 477 000 $
-
63 693 000 $
63 834 000 $
55 425 000 $
42 103 000 $
33 665 000 $
35 940 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
6 477 000 $
-
63 693 000 $
63 834 000 $
54 676 000 $
42 103 000 $
33 665 000 $
35 940 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-30 017 000 $
-24 303 000 $
-23 043 000 $
-25 396 000 $
-32 608 000 $
-32 608 000 $
-24 863 000 $
-24 595 000 $
-35 484 000 $
-31 050 000 $
-45 819 000 $
-37 946 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-8 822 000 $
-5 295 000 $
-15 547 000 $
-13 314 000 $
1 392 000 $
-
-16 638 000 $
-21 611 000 $
-21 018 000 $
-10 413 000 $
-27 116 000 $
-17 365 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-
17 963 000 $
13 756 000 $
17 273 000 $
23 723 000 $
23 723 000 $
19 788 000 $
17 489 000 $
25 055 000 $
14 409 000 $
16 190 000 $
13 483 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
41 604 000 $
38 052 000 $
32 518 000 $
34 853 000 $
39 085 000 $
-
88 556 000 $
88 429 000 $
45 876 000 $
71 347 000 $
78 979 000 $
73 008 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
317 993 000 $
261 571 000 $
237 737 000 $
199 799 000 $
136 549 000 $
111 207 000 $
159 518 000 $
171 524 000 $
200 157 000 $
183 181 000 $
184 087 000 $
190 180 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
391 043 000 $
328 834 000 $
295 879 000 $
268 573 000 $
200 538 000 $
140 993 000 $
224 919 000 $
236 866 000 $
265 075 000 $
245 950 000 $
245 091 000 $
249 846 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
289 897 000 $
233 351 000 $
218 389 000 $
183 278 000 $
116 444 000 $
65 508 000 $
95 867 000 $
98 591 000 $
142 448 000 $
131 302 000 $
110 536 000 $
144 344 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
48 957 000 $
55 614 000 $
70 775 000 $
62 158 000 $
12 651 000 $
13 228 000 $
12 956 000 $
6 218 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
165 300 000 $
151 902 000 $
156 219 000 $
167 788 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
149 829 000 $
121 250 000 $
140 282 000 $
140 601 000 $
86 095 000 $
66 509 000 $
63 618 000 $
46 954 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
74.71 %
86 %
62.37 %
59.36 %
32.48 %
27.04 %
25.96 %
18.79 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
105 899 000 $
100 335 000 $
97 108 000 $
60 474 000 $
20 816 000 $
1 851 000 $
37 772 000 $
43 932 000 $
41 651 000 $
52 573 000 $
36 944 000 $
72 271 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-25 325 000 $
-25 325 000 $
-22 534 000 $
-27 726 000 $
-27 575 000 $
-23 950 000 $
-26 111 000 $
-23 894 000 $
Last revenue report of Fortress Biotech, Inc. was 31/03/2021. According to last financial report total revenue in Fortress Biotech, Inc. was 11 587 000 US dollar and changed by +78.89% since last year. Net income in Fortress Biotech, Inc. was -8 822 000 $ in last quartal, net income changes to -733.764%.
Current cash Fortress Biotech, Inc. - the sum of all of the cash a company has on the date of report. Current cash Fortress Biotech, Inc. is 289 897 000 $
Fortress Biotech, Inc. stocks data
FBIO stock price
Fortress Biotech, Inc. stock price today, FBIO stock quote.
